We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.9B
AUM Growth
+$642M
Cap. Flow
-$3.41B
Cap. Flow %
-21.39%
Top 10 Hldgs %
20.34%
Holding
654
New
84
Increased
139
Reduced
145
Closed
63

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.93%
2 Technology 12.01%
3 Financials 11.15%
4 Industrials 8.36%
5 Healthcare 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$161B
$144M 0.91%
2,299,209
-1,452,155
-39% -$86.8M
CBI
27
DELISTED
Chicago Bridge & Iron Nv
CBI
$142M 0.89%
2,088,692
+376,694
+22% +$23.2M
PM icon
28
Philip Morris
PM
$301B
$138M 0.87%
1,593,927
-708,338
-31% -$61.9M
TROW icon
29
T. Rowe Price
TROW
$25B
$137M 0.86%
1,903,940
-931,686
-33% -$69M
LNKD
30
DELISTED
LinkedIn Corporation
LNKD
$136M 0.85%
551,028
+138,790
+34% +$31.3M
BEN icon
31
Franklin Resources
BEN
$16.9B
$127M 0.79%
2,507,034
-495,453
-17% -$23.9M
BKNG icon
32
Booking.com
BKNG
$138B
$125M 0.78%
3,083,450
-1,340,275
-30% -$50.1M
GM.PRB
33
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
$110M 0.69%
2,194,365
+447,465
+26% +$22.3M
JAZZ icon
34
Jazz Pharmaceuticals
JAZZ
$15.9B
$109M 0.68%
1,183,228
-5,374
-0.5% -$434K
REGN icon
35
Regeneron Pharmaceuticals
REGN
$68.8B
$105M 0.66%
334,221
+11,695
+4% +$3.08M
WFC.PRL icon
36
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$95.9M 0.6%
84,325
-22,844
-21% -$26.3M
LVS icon
37
Las Vegas Sands
LVS
$30.5B
$94.9M 0.6%
1,429,146
-207,015
-13% -$12M
MLU
38
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
$93.6M 0.59%
3,265,030
+404,746
+14% +$14.1M
GE icon
39
GE Aerospace
GE
$367B
$92.6M 0.58%
809,087
+7,002
+0.9% +$803K
MRK icon
40
Merck
MRK
$324B
$89.1M 0.56%
1,960,872
-83,657
-4% -$3.82M
UNP icon
41
Union Pacific
UNP
$183B
$86.6M 0.54%
1,115,456
+122,620
+12% +$9.69M
ORCL icon
42
Oracle
ORCL
$331B
$86.5M 0.54%
2,607,845
+2,710
+0.1% +$87.9K
RTX icon
43
RTX Corp
RTX
$287B
$85.2M 0.53%
1,255,078
+135,577
+12% +$8.87M
CSCO icon
44
Cisco
CSCO
$450B
$82.9M 0.52%
3,541,665
-164,575
-4% -$4.09M
CAM
45
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$79.9M 0.5%
1,369,281
-1,027
-0.1% -$61.2K
BX icon
46
Blackstone
BX
$104B
$78.9M 0.5%
3,231,302
+72,748
+2% +$1.62M
COV
47
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$75M 0.47%
1,230,961
-373,256
-23% -$22.8M
NKE icon
48
Nike
NKE
$61.9B
$71.7M 0.45%
1,975,136
-58,828
-3% -$1.92M
WSM icon
49
Williams-Sonoma
WSM
$26.7B
$71.2M 0.45%
2,532,326
+917,724
+57% +$26.6M
AXP icon
50
American Express
AXP
$223B
$68.1M 0.43%
902,398
+15,959
+2% +$1.2M

Similar funds

Calamos Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Calamos Advisors held 654 positions worth $15.9B, up 4.2% from $15.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $3.41B in Q3 2013, closing 63 positions and reducing 145 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Calamos Advisors opened a new position in Fortune Brands Innovations worth $50.3M.

  • Calamos Advisors's largest Q3 2013 buy was Fortune Brands Innovations: 1,412,443 shares worth $50.3M.
  • Calamos Advisors added most to Wells Fargo in Q3 2013, an estimated $120M increase.
  • Calamos Advisors's biggest Q3 2013 reduction was Qualcomm, cutting an estimated $242M.
  • Calamos Advisors fully exited ROCK-TENN COMPANY CL-A in Q3 2013, selling an estimated $43.9M.
  • Calamos Advisors's ten largest holdings make up 20% of its $15.9B portfolio in Q3 2013.
  • Calamos Advisors opened 84 new positions and closed 63 in Q3 2013.
  • Calamos Advisors's portfolio value rose 4.2% quarter-over-quarter to $15.9B.

Based on Calamos Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.